secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neuraxis, INC (NRXS)
CIK:        0001933567
Form:       8-K
Filed at:   2025-06-04T23:59:59+00:00
Accession:  0001641172-25-013632
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Neuraxis stockholders approve Series B conversion stock issuance; elect directors
--------------------------------------------------------------------------------

- Votes to approve issuance of 20%+ of outstanding common stock upon conversion of Series B Preferred Stock passed with 4.1M for, 129K against, 1.1M broker non-votes.
- All six director nominees elected: Brian Carrico, Dr. Christopher R Brown, Bradley Mitch Watkins, Beth Keyser, Kristen Ferge, Dr. Gilad Aharon.
- Ratification of auditor Rosenberg Rich Baker Berman, P.A. approved with 5.66M votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1933567/000164117225013632/0001641172-25-013632-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1933567/000164117225013632/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-013632

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer